AI Insight
Researchers used computational analysis and laboratory experiments to identify specific genetic mutations in tau protein that influence which disease-specific structural form it adopts when it misfolds. They discovered that mutations S341L and S352I together push tau toward forming structures associated with chronic traumatic encephalopathy (CTE) rather than Alzheimer's disease, demonstrating that small sequence changes can determine the disease-specific conformation of tau aggregates. The study analyzed approximately 12,000 possible mutations across six different tau disease structures to map which protein regions are most sensitive to changes.
Why it matters
This work provides a framework for understanding why tau protein misfolds differently in various brain diseases and could enable development of disease-specific diagnostic tools and biosensors. The ability to identify mutations that bias tau toward particular disease forms may help explain why different neurodegenerative diseases produce distinct clinical symptoms despite involving the same protein.
Understand the Science
⚠️ Preprint – Noch nicht peer-reviewed
Dieser Artikel wurde noch nicht von unabhängigen Experten begutachtet. Die Ergebnisse sind vorläufig und sollten mit Vorsicht interpretiert werden.
Tau amyloid fibrils adopt disease-specific structures across tauopathies, yet the sequence determinants that favor one pathological fold over another remain poorly defined. Here we combine computational saturation mutagenesis and energetic profiling, in vitro aggregation, cryo-EM and cellular seeding assays to identify sequence changes that alter tau fold compatibility. Across six tauopathy fibril structures, approximately 12,000 substitutions revealed that mutational sensitivity is concentrated within interaction networks formed by amyloidogenic motifs rather than uniformly distributed across the fibril core. Comparison of Alzheimer’s disease (AD) and chronic traumatic encephalopathy (CTE) folds identified residues within the 335-363 region that differentially influence fold compatibility. The S341L/S352I double mutant accelerated aggregation and remodeled packing within the PAM4-containing amyloidogenic region, producing an alternative amyloid architecture in a minimal tau fragment. S341L/S352I biosensors preferentially responded to CTE-derived over Alzheimer’s disease-derived seeds, while aggregates generated from recombinant S341L/S352I tau exhibited CTE-like cellular templating behavior. Although these assemblies are not established to reproduce the atomic CTE fold, the results demonstrate that targeted sequence changes can bias tau aggregation and propagation toward a CTE-compatible state. This framework provides a strategy for defining sequence-structure relationships in polymorphic amyloids and developing conformation-selective models and biosensors.
Source: Large-Scale Mutagenesis Identifies Sequence Changes That Bias Tau Toward CTE-like Aggregation